[Skip to Content]
[Skip to Content Landing]
Article
January 1983

Nodular Adrenal Hyperplasia With Elevated Adrenocorticotropic Hormone Levels

Author Affiliations

From the Departments of Medicine (Drs May, Schneider, and Ertel) and Pathology (Dr Sobel), Veterans Administration Medical Center, East Orange, NJ; and the University of Medicine and Dentistry of New Jersey-New Jersey Medical School, Newark (Drs May, Sobel, Schneider, and Ertel).

Arch Intern Med. 1983;143(1):136-140. doi:10.1001/archinte.1983.00350010146027
Abstract

• Micronodular adrenal hyperplasia is an uncommon adrenal disorder characterized by failure of urinary corticosteroid excretion to be suppressed by high-dose dexamethasone therapy. Thus, micronodular adrenal hyperplasia demonstrates dexamethasone suppressibility that resembles primary adrenal neoplasia. However, since some cases have been reported to have measurable plasma adrenocorticotropic hormone (ACTH) levels, it is unclear whether this disorder arises primarily in the pituitary-hypothalamic region or in the adrenal gland. Our patient had clinical features of Cushing's syndrome and elevated urinary corticosteroid excretion that did not suppress with even high doses of dexamethasone; however, ACTH levels were elevated and were suppressible with high-dose dexamethasone therapy. At operation, enlarged adrenal glands with multiple micronodules were found. This case is compatible with the hypothesis that hypothalamic-pituitary hyperfunction precedes the development of micronodular adrenal disease in some cases.

(Arch Intern Med 1983;143:136-140)

×